Inventor
Hannah Joy EDWARDS
Inventor
GB
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C07DHeterocyclic compounds29%
C07BGeneral methods of organic chemistry12%
PatentTitleYear
11,739,068Polymorphs of N-[(3-fluoro-4-methoxypyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide and salts thereof202311,613,527Enzyme inhibitors202311,242,333Inhibitors of plasma kallikrein202211,230,537Polymorphs of n-[(3-fluoro-4-methoxypyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[2-oxopyridin-1-yl)methyl]phenyl} methyl)pyrazole-4-carboxamide as iallikrein inhibitors202211,198,691N-((het)arylmethyl)-heteroaryl-carboxamides compounds as kallikrein inhibitors2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2023Patents assigned to KALVISTA PHARMACEUTICALS LTD (5)· patent assignee history
2021–2023Based in GB· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| KALVISTA PHARMACEUTICALS LTD | 5 | 2021–2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| GB | 5 | 2021–2023 |